Clinical Trial: Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: The Effect of Standard vs Aggressive Dosing Regimens for Epsilon-aminocaproic Acid on a Quantifiable Parameter of Fibrinolysis as Measured by Thromboelastography

Brief Summary: This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events